Wm Health 10-15 notes

by | Jan 19, 2015

Post Categories: Uncategorized

Dr. Tori Hudson graduated from the National College of Naturopathic Medicine (NCNM) in 1984 and has served the college in many capacities. She is currently clinical professor at NCNM and Bastyr University, has been in practice for over 31 years, and is medical director of the clinic A Woman’s Time in Portland, Oregon. She is the author of the book Women’s Encyclopedia of Natural Medicine; a contributing author to several books, including the Textbook of Natural Medicine; and director of research and education for Vitanica, a supplement company for women. She is a nationally recognized author, speaker, educator, researcher, and clinician.

Notes

1. Kessler R, Soukup J, Davis R, et al. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry. 2001;158:289–294.

2. Smit E, Muskiet F, Boersma E. The possible role of essential fatty acids in the pathophysiology of malnutrition: a review. Prostaglandins Leukot Essent Fat Acids. 2004;71(4):241–250.

3. Hibbeln J. Fish consumption and major depression. Lancet. April 18, 1998;351:1213.

4. Tanskanen A, Hibbeln J, Hintikka J, et al. Fish consumption and depression and suicidality in a general population. Arch Gen Psychiatry. 2001;58:512–513.

5. Hirayama T. Life-style and mortality: a large census-based cohort study in Japan. Basel: Karger; 1990.

6. Adams P, Lawson S, Sanigorski A, Sinclair A. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids. 1996;31:157–161.

7. McNamara R, Jandacek R, Rider T, et al. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J Affect Disord. 2010;126:303–311.

8. Weidner G, Connor S, Hollis J, Connor W. Improvements in hostility and depression in relation to dietary change and cholesterol lowering. Ann Intern Med. 1992;117:820–823.

9. Booth-Kewley S, Friedman HS. Psychological predictors of heart disease: a quantitative review. Psychol Bull. 1987;101(3):343–362.

10. Salem N, Ward G. The effects of ethanol on polyunsaturated fatty acid composition. In: Alling C, Diamond I, Leslie S, Sun G, Wood W, eds. Alcohol, Cell Membranes, and Signal Transduction in Brain. New York: Plenum Press, 1993:33–46.

11. Poudel-Tandukar K, Nanri A, Iwasaki M, et al. Long chain n-3 fatty acids intake, fish consumption and suicide in a cohort of Japanese men and women– The Japan Public Health Center-based prospective study. J Affect Disord. 2011;129:282–288.

12. Appleton K, Hayward R, Gunnell D, et al. Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr. 2006;84(6):1308–1316.

13. Ross B, Seguin J, Sieswerda L. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids Health Dis. Sept. 18, 2007;6:21.

14. Lin P, Su K. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007;68(7):1056–1061.

15. Freeman M, Hibbeln J, Wisner K, et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 2006;67(12):1954–1967.

16. Williams A, Katz D, Ali A, et al. Do essential fatty acids have a role in the treatment of depression. J Affect Disord. 2006;93:117–123.

17. Stoll A, Severus W, Freeman M, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999;56:407–412.

18. Maes M, Christophe A, Delanghe J, et al. Lowered omega 3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 1999;85:275–291.

19. Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord. 1998;48(2–3):149–155.

20. Peete M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry. 1998;43(5):315–319.

21. Horrocks L, Yeo Y. Health benefits of docosahexaenoic acid (DHA). Pharmacol Res. 1999;22(5–6):474–480.

22. Bruinsma K, Taren D. Dieting, essential fatty acid intake, and depression. Nutr Rev. 2000;58(4):98–108.

23. Su K, Huang S, Chiu C, Shen W. Omega-3 fatty acids in major depressive disorder–a preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol. 2003;13:267–271.

24. Peet M, Horrobin D. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 2002;59 (10):913–319.

25. Nemets B, Stahl Z, Belmaker R. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry. 2002;159:477–479.

26. Gertsik L, Poland R, Bresee C, et al. Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder. J Clin Psychopharmacol. 2012;32(1):61–64.

27. Freeman M, Hibbeln J, Silver M, et al. Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: preliminary open trial. Menopause. 2011 18(3):279–284.

28. Lesperance F, Frasure-Smith N, St-Andre E, et al. The efficacy of omega-3 supplementation for major depression: a randomized controlled trial. J Clin Psychiatry. 2011;72(8):1054–1062.

29. Marangell L, Martinez J, Zboyan H, et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry. 2003;160 (5):996–998.

30. Mischoulan D, Best-Popescu C, Laposata M, et al. A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. Eur Neuropsychopharmacol. 2008;18:639–645.

31. Haberka M, Mizia-Stec K, Mizia M, et al. Effects of n-3 polyunsaturated fatty acids on depressive symptoms, anxiety and emotional state in patients with acute myocardial infarction. Pharmacol Rep. 2013;65:59–68.

32. Mozaffari-Khosravi H, Yassini-Ardakani M, Karamati M, et al. Eicosapentaenoic acid versus docosahexaenoic acid in mild-to moderate depression: A randomized, double-blind, placebo-controlled trial. Eur Neuropsychopharmacol. 2013;23:636–644.

33. Jazayeri S, Tehrani-Doost M, Keshavarz SA, et al. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Aust N Z J Psychiatry. 2008 Mar;42(3):192–198.

34. Grosso G, Pajak A, Maventano S, et al. Role of omega fatty acids in the treatment of depressive disorders. A comprehensive meta-analysis of randomized controlled trials. PLOS One. 2014;9(5):e96905.

35. Rice S, Hickie I, Yung A, et al. Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial. Early Interv Psychiatry. Epub 2014 Aug 13.

36. Hegarty B, Parker G. Fish oil as a management component for mood disorders – an evolving signal. Curr Opin Psychiatry. 2013 Jan;26(1):33–40.

Author

Already Subscribed?

Search

Formatting updates are ongoing for older articles.

Author

Featured Articles

Where are your Clinical Trials?

It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized. 

A Renewed Focus on Self-Help for Healing

As the producer of The Moss Report, the year leading up to the Covid-19 pandemic was filled with anticipation and excitement. We had invested years of hard work and significant resources into two major projects: our feature film, Immunotherapy: The Battle Within, and...

Issue Archives

Event Calendar

  • 2026 Association of Natural Health Conference

    Douglasville Conference Center Douglasville, GA, United States

    "From Practitioner to Leader: Clinical Excellence, Business Mastery & Sustainable Practice" Discover how clinical excellence, business mastery, and sustainable systems can help practitioners grow into confident leaders and build practices designed for long-term impact. Why Attend? Three days of learning, connection, and growth designed for every stage of your practice journey. Learn from Leading Voices Gain insights from top experts in natural health, holistic wellness, and functional medicine. Hands-On Learning Participate in in-depth workshops, real-world case studies, and interactive sessions you can apply immediately. Meaningful Networking Connect with like-minded professionals, students, and exhibitors who share your passion for natural health. Practical Tools & Approaches Explore new strategies and tools to elevate both your practice and your own health journey. Who Should Attend? This conference is built for a wide community of natural health professionals, educators, and advocates - wherever you are in your journey. Licensed & Clinical Practitioners Doctors, chiropractors, acupuncturists, naturopaths, and functional or integrative medicine practitioners looking to sharpen clinical skills and grow into stronger practice leaders. Allied Health Professionals Bio-feedback technicians and other allied practitioners seeking hands-on training and the latest tools in natural and holistic care. Educators & Students Natural health educators and students entering the […]

  • Food as Medicine Global 2026

    Virtual Event

    Join health professionals, farmers, food producers, researchers, educators, nonprofit leaders, chefs, policymakers, community organizers, food advocates, public health practitioners, nutritionists, and other changemakers as we convene to share knowledge, build partnerships, and explore new possibilities for improving health, strengthening communities, and creating more equitable and sustainable food systems. This year’s program features inspiring speakers and practical examples of collaboration at the intersection of food, health, social justice, and planetary well-being. Together, we’ll explore innovative approaches to Food as Medicine, community-led initiatives, nutrition, public health, regenerative agriculture, and equitable access to healthy food. Whether you work in health care, agriculture, food production, education, research, policy, or community development, you will discover new ideas, meaningful connections, and practical strategies to advance healthier, more resilient communities. Virtual  |  Join from anywhere in the world Check out the Program: https://tinyurl.com/Food-as-Medicine-for-All

  • The Midlife Women’s Health Summit: Evidence-Based Menopause Care in the Era of Longevity Medicine

    The Ritz-Carlton, Pentagon City 1250 S Hayes St, Arlington, VA, United States
    Hybrid Event

    Menopause Care in the Longevity Era Longevity medicine is everywhere right now. Supplements, protocols, influencer clinics, patients walking in with questions about interventions their doctors have never heard of. What's missing from most of it is the evidence. The Midlife Women's Health Summit is three days on what the research actually says about menopause care when you add a longevity lens. What works, what doesn't, what's being oversold, and what to tell the patient sitting in front of you. Co-chaired by Lisa Larkin, MD, FACP, MSCP, IF, Jen Gunter, MD, FRCS(C), FACOG, DABPM, ABPMR, and Lauren Streicher, MD, FACOG, MSCP; three of the clearest voices in women's health on separating data from marketing.

    $995 – $1299

Related Posts

You Deserve a Beautiful Life

by Gary Null, PhD – How many times have we gone against the current of our own being? You know you should do A, but you are conditioned to do B.

You are fighting it because the conditioned self is conditioned from a place of fear. And fear will always win if we give in to it.

Read More

Increase Sperm Count, Improve Fertility and Decrease Cancer Risk

By Erik Peper, PhD – The recently released Netflix documentary The Plastic Detox offers an eye-opening exploration of the hidden dangers of the chemicals in plastics in our homes and daily lives. It highlights concerns ranging from hormone disruption—which may contribute to declining fertility worldwide—to increasing rates of cancer and earlier occurrences of heart attack and stroke.

Read More

A Powerful New (and Old!) Treatment for Pain, POTS, MCAS, Lyme and Postinfectious Fibromyalgia

by Jacob Teitelbaum, MD – “PEA is thought to be produced as a protective response to cellular injury…effects include…analgesic, anticonvulsant, antimicrobial,…immunomodulatory and neuroprotective activities. PEA’s multi-faceted effects are due to its unique mechanisms of action.” It also helps your immune system with viruses, bacteria, and “leaky gut.”

Read More

0 Comments

Submit a Comment